ASH 2023 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, MPE, Myeloma15 December 2023
EMA CHMP confirms recommendation for non-renewal of Blenrep marketing authorisationAccess, MPE15 December 2023
